Published in Hypertension on August 15, 2016
Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is Relevant. Hypertension (2017) 0.75
Association of aldosterone excess and apnea-hypopnea index in patients with resistant hypertension. Sci Rep (2017) 0.75
Relationship and associated mechanisms between ambulatory blood pressure and clinic blood pressure with prevalent cardiovascular disease in diabetic hypertensive patients. Medicine (Baltimore) (2017) 0.75
Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension. Am J Hypertens (2016) 0.75
Controlling Hypertension: We Have the Tools-We Just Need to Use Them. J Gen Intern Med (2017) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res (1998) 50.73
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Adipose tissue as an endocrine organ. J Clin Endocrinol Metab (2004) 11.94
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev (2000) 8.15
Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med (2003) 5.38
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation (2008) 5.26
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation (1991) 4.65
Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev (2009) 4.35
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation (2011) 3.95
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens (2001) 2.95
Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens (2003) 2.54
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med (1992) 2.54
Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension (2002) 2.46
Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med (2009) 2.25
The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med (1981) 2.05
Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study. Hypertension (2010) 1.85
Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens (2002) 1.79
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab (2007) 1.78
Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A (2003) 1.74
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials. Hypertension (2003) 1.71
Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community. Hypertension (2000) 1.70
Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration. Clin J Am Soc Nephrol (2010) 1.65
Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J (2005) 1.65
Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest (2007) 1.65
The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol (2003) 1.65
Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens (2009) 1.64
Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension (2012) 1.63
Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans. Am J Hypertens (2009) 1.60
Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol (2006) 1.49
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab (2008) 1.38
Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab (2005) 1.36
Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol (2010) 1.35
Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res (1999) 1.34
Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation (2004) 1.28
A novel adipokine CTRP1 stimulates aldosterone production. FASEB J (2008) 1.20
Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension (2004) 1.17
Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med (2010) 1.15
Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Prog Cardiovasc Dis (2010) 1.12
Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin Chem (2002) 1.11
Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N Engl J Med (1989) 1.09
Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol (1986) 1.04
Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids (2000) 1.03
Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females. Circ Res (2016) 0.99
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol Cell Endocrinol (2011) 0.98
Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice. Hypertension (2015) 0.97
Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity. Nutr Metab Cardiovasc Dis (2008) 0.96
Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway. Int J Obes (Lond) (2007) 0.95
Regulation of aldosterone secretion in hypertensive blacks. Hypertension (1994) 0.94
Clinical characteristics of patients with resistant hypertension: the RESIST-POL study. J Hum Hypertens (2013) 0.94
Aldosterone-induced cardiac damage: focus on blood pressure independent effects. Am J Hypertens (2003) 0.91
A reference method for the analysis of aldosterone in blood by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. Anal Biochem (1997) 0.91
Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II-sensitization in human adrenocortical cells. Int J Obes (Lond) (2007) 0.89
Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis. Circulation (2015) 0.88
Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens (1994) 0.88
Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice. Am J Physiol Heart Circ Physiol (2015) 0.88
Insulin, renin-aldosterone system and blood pressure in obese people. Int J Obes Relat Metab Disord (2001) 0.87
Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients. J Clin Endocrinol Metab (1981) 0.85
Aldosterone contributes to elevated left ventricular mass in black boys. Pediatr Nephrol (2012) 0.84
Simultaneous measurement of aldosterone and cortisol by high-performance liquid chromatography-tandem mass spectrometry: application to dehydration-rehydration studies. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.83
Familial and phenotypic associations of the aldosterone Renin ratio. J Clin Endocrinol Metab (2009) 0.81
Measurement of plasma renin activity with use of HPLC-electrospray-tandem mass spectrometry. Clin Chem (1999) 0.80
ERK1/2 MAPKs and Wnt signaling pathways are independently involved in adipocytokine-mediated aldosterone secretion. Exp Clin Endocrinol Diabetes (2011) 0.78
Pheochromocytoma and primary aldosteronism: diagnostic approaches. Endocrinol Metab Clin North Am (1997) 0.78
Local formation of angiotensin peptides with paracrine activity by adipocytes. J Pept Sci (2009) 0.77